Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Brixner

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
BMC Health Services Research|December 31, 2018
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in IndonesiaAndras Inotai, Diana Brixner, Nikos Maniadakis, et al.
Journal of Managed Care & Specialty Pharmacy|March 1, 2019
Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic AgentsKibum Kim, Sudhir Unni, Carrie McAdam-Marx, et al.
Interventional Pain Medicine|December 3, 2024
The relationship of PROMIS physical function scores and healthcare resource utilization in patients treated for chronic low back painAndre Hejazi, Connor Willis, Xiangyang Ye, et al.
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
The impact of a statewide insulin copay cap policy for insured patients with diabetes in UtahNiying Li, Rupesh Panchal, Theodoros Giannouchos, et al.
Leukemia & Lymphoma|October 29, 2013
Medical decision analysis for first-line therapy of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
Advances in Therapy|December 20, 2024
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory DiseasesMin Yang, Manish Mittal, A Mark Fendrick, et al.
Journal of Managed Care & Specialty Pharmacy|June 15, 2023
The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United StatesRupesh Panchal, Madeline Brendle, Sabrina Ilham, et al.
Journal of Medical Internet Research|November 17, 2025
Effects of a Digital Health Intervention for Adults With Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort StudyLaura Wilson, Daniel Malone, Praveen Potukuchi, et al.
BMC Cancer|October 18, 2017
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!OnlineBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Leukemia & Lymphoma|November 14, 2014
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
BMC Health Services Research|December 31, 2018
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in IndonesiaAndras Inotai, Diana Brixner, Nikos Maniadakis, et al.
Journal of Managed Care & Specialty Pharmacy|March 1, 2019
Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic AgentsKibum Kim, Sudhir Unni, Carrie McAdam-Marx, et al.
Interventional Pain Medicine|December 3, 2024
The relationship of PROMIS physical function scores and healthcare resource utilization in patients treated for chronic low back painAndre Hejazi, Connor Willis, Xiangyang Ye, et al.
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
The impact of a statewide insulin copay cap policy for insured patients with diabetes in UtahNiying Li, Rupesh Panchal, Theodoros Giannouchos, et al.
Leukemia & Lymphoma|October 29, 2013
Medical decision analysis for first-line therapy of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
Advances in Therapy|December 20, 2024
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory DiseasesMin Yang, Manish Mittal, A Mark Fendrick, et al.
Journal of Managed Care & Specialty Pharmacy|June 15, 2023
The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United StatesRupesh Panchal, Madeline Brendle, Sabrina Ilham, et al.
Journal of Medical Internet Research|November 17, 2025
Effects of a Digital Health Intervention for Adults With Type 2 Diabetes Mellitus on Health Care Resource Use and Health Care Charges in the United States: Retrospective Cohort StudyLaura Wilson, Daniel Malone, Praveen Potukuchi, et al.
BMC Cancer|October 18, 2017
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!OnlineBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Leukemia & Lymphoma|November 14, 2014
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
Pageof 11